Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GSK in 2013. It focuses on investing in bioelectronic medicine and technology companies, taking a hands-on role on the boards of its portfolio companies. APVC is GSK's bioelectronic medicines venture fund, emphasizing the next generation of peripheral neuromodulation technologies.
Focus Areas
Investment Types
Notable Investments
